These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36545230)

  • 41. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
    Yancy CW; Jessup M; Bozkurt B; Butler J; Casey DE; Colvin MM; Drazner MH; Filippatos GS; Fonarow GC; Givertz MM; Hollenberg SM; Lindenfeld J; Masoudi FA; McBride PE; Peterson PN; Stevenson LW; Westlake C
    J Card Fail; 2017 Aug; 23(8):628-651. PubMed ID: 28461259
    [No Abstract]   [Full Text] [Related]  

  • 42. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
    Xiang B; Zhang R; Wu X; Zhou X
    JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [European guidelines on heart failure: pharmacotherapy].
    Grundmann S; von Zur Mühlen C
    Herz; 2023 Mar; 48(2):89-94. PubMed ID: 36695878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
    ;
    J Card Fail; 2016 Sep; 22(9):659-69. PubMed ID: 27394189
    [No Abstract]   [Full Text] [Related]  

  • 45. Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction.
    Blair HA
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):701-710. PubMed ID: 34651263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction - a practical approach.
    Nessler J
    Postepy Kardiol Interwencyjnej; 2021 Jun; 17(2):135-140. PubMed ID: 34400915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic heart failure: developments and perspectives.
    Crouch MA
    Consult Pharm; 2005 Sep; 20(9):751-65. PubMed ID: 16548668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of Heart Failure With Reduced Ejection Fraction.
    Rashid AM; Khan MS; Fudim M; DeWald TA; DeVore A; Butler J
    Curr Probl Cardiol; 2023 May; 48(5):101596. PubMed ID: 36681212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Greenberg B
    Korean Circ J; 2022 Mar; 52(3):173-197. PubMed ID: 35257531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The new ESC Guidelines for acute and chronic heart failure 2016].
    Oeing CU; Tschöpe C; Pieske B
    Herz; 2016 Dec; 41(8):655-663. PubMed ID: 27858115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Palliative care in heart failure guidelines: A comparison of the 2021 ESC and the 2022 AHA/ACC/HFSA guidelines on heart failure.
    Blum M; Goldstein NE; Jaarsma T; Allen LA; Gelfman LP
    Eur J Heart Fail; 2023 Oct; 25(10):1849-1855. PubMed ID: 37492904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Sorajja P; Gössl M; Garcia S; Jneid H; Kakouros N; Martinez-Parachini JR; Resendes E; Kalsaria P; Roesle M; Rangan BV; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Sep; 29(9):320-326. PubMed ID: 28420803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vericiguat, organic nitrates, and heart failure in African Americans.
    Ilonze OJ; Guglin M
    Int J Cardiol; 2021 Sep; 338():136-137. PubMed ID: 34157357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart Failure With Reduced Ejection Fraction: A Review.
    Murphy SP; Ibrahim NE; Januzzi JL
    JAMA; 2020 Aug; 324(5):488-504. PubMed ID: 32749493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium-glucose co-transporter 2 inhibitors?
    Berezin AE; Berezin AA
    Future Cardiol; 2021 May; 17(3):497-506. PubMed ID: 33615880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
    Sharma A; Verma S; Bhatt DL; Connelly KA; Swiggum E; Vaduganathan M; Zieroth S; Butler J
    JACC Basic Transl Sci; 2022 May; 7(5):504-517. PubMed ID: 35663626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.